BINV
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
BioInvent International is a biotechnology company focused on the development of antibody therapies for cancer treatment. The company researches new treatments that can improve patient outcomes and quality of life. The company operates globally with a presence in international markets. BioInvent International was founded in 1983 and is headquartered in Lund.
Læs mereDelårsrapport Q2'26
Delårsrapport Q3'26
Omsætning mio.
EBIT-% (adj.)
EPS (adj.)
Udbytte %
Gå ikke glip af noget - opret en konto og få alle de mulige fordele